RHNanoPharma

Arthritis

Inflammation of one or more joints, causing pain and stiffness that can worsen with age.

Nuclear factor kappa B is the master controller of inflammation at cellular level

"Salsalate reduces inflammation"
DIABETES Mellitus

Chronic inflammation results in pancreatic dysfunction, leading to Diabetes Mellitus

Salsalate reduces HbA1C
Operative analgesia

Narcotic pain management in postoperative patients leads to addiction

Salsalate = Opioid sparing
Traumatic brain injury

Life after brain injury

"I" am not the same "me"

Salsalate proven effective in animal model of TBI
Alzheimer's disease and dementia

Its hard to cure Dementia. Lets still be hopeful!

Salsalate proven effective in animal model of AD

Product Pipeline

RH Nanopharma has developed and continues to develop new formulations of salsalate:

Oral tablets, capsules, and soft gel caps of immediate release salsalate
Liquid formulation of immediate release salsalate
Nanosupsensions of salsalate for Intravenous use in reducing operative pain
Topical gels for soft tissue injury/pain using nanoparticles of salsalate
Ocular nanosuspensions for Dry Eye Disease (DED)
Nanosupension of oral salsalate for immediate relief of pain (Pre-IND Meeting successful - June 2018, IND submission in progress)

Our Mission

RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases.

Arthritis

DIABETES Mellitus

Operative analgesia

Traumatic brain injury

Alzheimer's disease and dementia

Product Pipeline

Future of Nanomedicine

Our Mission

News and Events

CONTACT